PP01.29: Low Dose Durvalumab Consolidation After Definitive Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer – A Real-World Multicentre Experience From India
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Lung Cancer Diagnosis and Treatment
Lung Cancer Treatments and Mutations
Publication details
- Journal / source
- Journal of Thoracic Oncology
- Volume
- 21
- Issue
- 1
- Pages
- S19–S19
- Publication date
- 1 January 2026
- Language
- EN